CVSA Covista Inc. Common Shares

NYSE · Diversified Consumer Services · Wyświetl na SEC EDGAR ↗
$134,92
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 6, 2026

O Covista Inc. Common Shares Przegląd firmy z Wikipedii

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Czytaj więcej

Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.

Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.

History

DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.

In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.

In November 2013, DeVry Inc. was renamed DeVry Education Group.

Rebranding from DeVry Education Group to Adtalem Global Education

Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.

Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."

The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.

Acquisitions and divestitures

Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.

At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.

Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.

Operations

Campuses and enrollment

Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.

Leadership

Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.

Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.

Finances

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.

Controversies

Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.

In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.

Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.

For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.

As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.

In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.

A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.

In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.

In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.

In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

CVSA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$134.91
Kapitalizacja Rynkowa
$4.59B
P/E (TTM)
19.2
EPS (TTM)
$7.04
Przychody (TTM)
$1.95B
Stopa dywidendy
ROE
17.8%
D/E Dług/Kapitał
0.5
Zakres 52 tyg.
$87 – $156

CVSA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $1.95B
6-point trend, +117.3%
2021-06-30 2026-06-30
EPS $7.04
6-point trend, +417.6%
2021-06-30 2026-06-30
Wolny przepływ pieniężny $393M
6-point trend, +173.6%
2021-06-30 2026-06-30
Marże 12.9%

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza
P/E (TTM)
5-point trend, +216.5%
19.2
15.2
P/S (TTM)
5-point trend, +84.6%
2.3
1.8
P/B
5-point trend, +171.7%
3.2
3.6
EV / EBITDA
5-point trend, -55.4%
12.6
Price / FCF (Cena / FCF)
5-point trend, +113.7%
11.7

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
5-point trend, +238.3%
19.6%
Net Profit Margin (Marża Zysku Netto)
5-point trend, -43.8%
12.9%
11.7%
ROA
5-point trend, -10.0%
8.7%
7.9%
ROE
5-point trend, -16.3%
17.8%
15.8%
ROIC
5-point trend, +520.3%
14.1%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
5-point trend, -17.8%
0.5
Current Ratio (Wskaźnik bieżący)
5-point trend, -17.9%
1.1
1.7
Quick Ratio (Wskaźnik Szybkości)
5-point trend, -5.9%
1.0

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, +41.4%
9.3%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, +41.4%
10.4%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, +41.4%
16.8%
EPS YoY
5-point trend, +9.5%
13.9%
Net Income YoY (Zysk Netto R/R)
5-point trend, -19.1%
6.1%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, +9.5%
$7.04

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
CVSA
Mediana porównawcza

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

Stopa Dywidendy
Wskaźnik Wypłaty Dywidendy
CAGR dywidendy 5-letni
Data ex-dywidendyKwota
30 listopada 2016$0,1800
1 czerwca 2016$0,1800
2 grudnia 2015$0,1800
3 czerwca 2015$0,1800
3 grudnia 2014$0,1800
4 czerwca 2014$0,1700
4 grudnia 2013$0,1700
5 czerwca 2013$0,1700
28 listopada 2012$0,1700
19 czerwca 2012$0,1500
6 grudnia 2011$0,1500
16 czerwca 2011$0,1200
8 grudnia 2010$0,1200
11 czerwca 2010$0,1000
9 grudnia 2009$0,1000
12 czerwca 2009$0,0800
10 grudnia 2008$0,0800
17 czerwca 2008$0,0600
12 grudnia 2007$0,0600
14 czerwca 2007$0,0500

CVSA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 10 analityków
  • Mocne kupno 4 40,0%
  • Kup 5 50,0%
  • Trzymaj 1 10,0%
  • Sprzedaj 0 0,0%
  • Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

4 analityków · 2026-08-18
Średni cel $161.50 +19,7%
Średnia cel $159.50 +18,2%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
0.18%
Okres EPS Actual EPS Szacowany Niespodzianka
30 czerwca 2026 $2.09 $1.93 0.16%
31 marca 2026 $1.98 $1.76 0.22%
31 grudnia 2025 $2.43 $2.23 0.20%
30 września 2025 $1.75 $1.61 0.14%
30 czerwca 2025 $1.66 $1.56 0.10%
31 marca 2025 $1.92 $1.69 0.23%

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
CVSA $4.24B 17.7 9.3% 12.9% 17.8%
DUOL $8.18B 20.5 38.7% 39.9% 35.6% 72.2%
LAUR $4.81B 17.8 8.6% 16.6% 26.2%
GHC 16.5 2.5% 5.9% 6.5%
LOPE $4.56B 21.6 7.1% 19.5% 28.3%
LRN $3.58B 12.1 4.7% 13.4% 21.3% 37.8%
BFAM $5.64B 30.2 9.2% 6.6% 14.1% 23.8%
MH $2.62B 72.1 0.07% 1.7% 4.6% 80.9%
PRDO $1.83B 12.1 24.2% 18.9% 16.3%
STRA $1.84B 14.8 4.0% 10.0% 7.6%
UTI $1.77B 28.8 14.1% 7.5% 20.3%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 16
Dane roczne Rachunek zysków i strat dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Revenue 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Cost of Revenue 5-point trend, +26.4% $834M $771M $699M $648M $660M · · ·
SG&A Expense 5-point trend, +29.0% $731M $672M $633M $586M $566M · · ·
Operating Expenses 5-point trend, +20.4% $1.57B $1.45B $1.37B $1.28B $1.31B · · ·
Operating Income 5-point trend, +399.5% $383M $342M $217M $168M $77M · · ·
Interest Expense 5-point trend, -64.9% $45M $52M $64M $63M $129M · · ·
Interest Income · · · · $4M · · ·
Other Non-op 5-point trend, +547.8% $7M $9M $11M $7M $1M · · ·
Pretax Income 5-point trend, +770.2% $345M $299M $164M $112M $-51M · · ·
Income Tax 5-point trend, +600.3% $78M $66M $26M $10M $-16M · · ·
Net Income 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
EPS (Basic) 5-point trend, +11.7% $7.18 $6.39 $3.47 $2.08 $6.43 · · ·
EPS (Diluted) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Shares (Basic) 5-point trend, -27.6% 35,045,000 37,085,000 39,413,000 44,781,000 48,388,000 · · ·
Shares (Diluted) 5-point trend, -26.2% 35,715,000 38,334,000 40,307,000 45,600,000 48,388,000 · · ·
EBITDA 5-point trend, +376.5% $383M $342M $217M $168M $80M · · ·
Bilans 28
Dane roczne Bilans dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Cash & Equivalents 8-point trend, +503.9% $406M $200M $219M $272M $347M $275M $416M $67M
Short-term Investments · · · · · · · $9M
Receivables 7-point trend, +141.6% $167M $143M $124M $100M $79M $90M $69M ·
Prepaid Expense 8-point trend, +65.9% $75M $69M $70M $102M $128M $167M $97M $45M
Current Assets 8-point trend, +67.3% $652M $416M $418M $480M $557M $611M $681M $390M
PP&E (Net) 8-point trend, +7.3% $303M $256M $249M $245M $290M $302M $279M $282M
PP&E (Gross) 8-point trend, +13.3% $686M $598M $575M $583M $666M $663M $618M $605M
Accum. Depreciation 8-point trend, +18.5% $383M $342M $326M $339M $376M $362M $339M $323M
Goodwill 8-point trend, +40.0% $961M $961M $961M $961M $961M $960M $310M $687M
Intangibles 8-point trend, +157.7% $754M $765M $777M $812M $874M $924M $138M $293M
Other Non-current Assets 8-point trend, +66.2% $138M $129M $103M $81M $119M $118M $88M $83M
Total Assets 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Accounts Payable 8-point trend, +296.6% $125M $105M $103M $82M $57M $65M $39M $31M
Accrued Liabilities 8-point trend, +5.4% $94M $77M $97M $106M $98M $135M $97M $90M
Current Liabilities 8-point trend, +96.2% $597M $508M $488M $431M $424M $497M $341M $304M
Capital Leases 8-point trend, +15.5% $208M $186M $168M $163M $177M $156M $194M $180M
Deferred Tax 8-point trend, +148.0% $62M $32M $30M $26M $26M $27M $25M $25M
Other Non-current Liabilities 8-point trend, -52.4% $42M $40M $39M $37M $74M $58M $81M $89M
Total Liabilities 8-point trend, +43.4% $1.57B $1.32B $1.37B $1.35B $1.54B $2.37B $959M $1.09B
Long-term Debt 8-point trend, +59.7% $663M $553M $649M $695M $839M $1.61B $287M $415M
Total Debt 5-point trend, -21.0% $663M $553M $649M $695M $839M · · ·
Common Stock 8-point trend, +5.2% $848.0K $839.0K $832.0K $822.0K $818.0K $817.0K $810.0K $806.0K
Retained Earnings 8-point trend, +49.0% $3.03B $2.78B $2.54B $2.40B $2.31B $1.96B $1.97B $2.03B
Treasury Stock 8-point trend, +112.6% $2.29B $2.01B $1.78B $1.51B $1.34B $1.22B $1.16B $1.08B
AOCI 8-point trend, +98.6% $-2M $-2M $-2M $-2M $-2M $-634.0K $-8M $-159M
Stockholders' Equity 8-point trend, +11.7% $1.45B $1.43B $1.37B $1.46B $1.49B $1.28B $1.31B $1.29B
Liabilities + Equity 8-point trend, +26.0% $3.01B $2.75B $2.74B $2.81B $3.03B $3.66B $2.27B $2.39B
Shares Outstanding 8-point trend, -35.7% 34,033,000 35,952,000 37,681,000 82,232,000 81,796,000 81,705,000 81,021,000 52,953,000
Przepływy pieniężne 16
Dane roczne Przepływy pieniężne dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Stock-based Comp 5-point trend, +82.3% $41M $42M $26M $14M $23M · · ·
Deferred Tax 5-point trend, +600.7% $68M $18M $11M $-5M $-14M · · ·
Amort. of Intangibles 5-point trend, -88.5% $11M $11M $36M $61M $97M · · ·
Restructuring 5-point trend, -75.3% $6M $3M $2M $19M $26M · · ·
Operating Cash Flow 5-point trend, +4337.5% $470M $338M $296M $192M $11M · · ·
CapEx 5-point trend, +150.2% $78M $50M $49M $26M $31M · · ·
Investing Cash Flow 5-point trend, +84.8% $-84M $-42M $-48M $24M $-552M · · ·
Debt Issued 5-point trend, +18.5% $1.01B $10M $2M $0 $850M · · ·
Net Debt Issued 5-point trend, +148.8% $112M $-100M $-50M $-151M $-230M · · ·
Stock Repurchased 5-point trend, +99.9% $240M $213M $262M $123M $120M · · ·
Net Stock Activity 5-point trend, -99.9% $-240M $-213M $-262M $-123M $-120M · · ·
Financing Cash Flow 5-point trend, +57.6% $-180M $-316M $-302M $-289M $-424M · · ·
Net Change in Cash 5-point trend, +121.4% $207M $-20M $-54M $-73M $-966M · · ·
Taxes Paid 5-point trend, -85.5% $14M $33M $31M $12M $94M · · ·
Free Cash Flow 5-point trend, +2003.7% $393M $288M $247M $166M $-21M · · ·
Levered FCF 5-point trend, +436.5% $358M $247M $193M $109M $-106M · · ·
Rentowność 7
Dane roczne Rentowność dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Operating Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
Net Margin 5-point trend, -43.8% 12.9% 13.3% 8.6% 6.4% 22.9% · · ·
Pretax Margin 5-point trend, +643.4% 17.7% 16.7% 10.3% 7.7% -3.2% · · ·
EBITDA Margin 5-point trend, +238.3% 19.6% 19.1% 13.7% 11.6% 5.8% · · ·
ROA 5-point trend, -10.0% 8.7% 8.6% 4.9% 3.3% 9.7% · · ·
ROE 5-point trend, -16.3% 17.8% 16.5% 10.2% 6.3% 21.3% · · ·
ROIC 5-point trend, +520.3% 14.1% 13.4% 9.0% 7.1% 2.3% · · ·
Płynność i wypłacalność 5
Dane roczne Płynność i wypłacalność dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Current Ratio 5-point trend, -17.9% 1.1 0.8 0.9 1.1 1.3 · · ·
Quick Ratio 5-point trend, -5.9% 1.0 0.7 0.7 0.9 1.0 · · ·
Debt / Equity 5-point trend, -17.8% 0.5 0.4 0.5 0.5 0.6 · · ·
LT Debt / Equity 5-point trend, -18.4% 0.5 0.4 0.5 0.5 0.6 · · ·
Interest Coverage 5-point trend, +1256.4% 8.4 6.5 3.4 2.7 0.6 · · ·
Efektywność 2
Dane roczne Efektywność dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Asset Turnover 5-point trend, +60.0% 0.7 0.7 0.6 0.5 0.4 · · ·
Receivables Turnover 5-point trend, -21.6% 12.6 13.4 14.1 16.2 16.1 · · ·
Na akcję 5
Dane roczne Na akcję dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Book Value / Share 5-point trend, +27.6% $42.49 $39.88 $36.33 $34.44 $33.31 · · ·
Revenue / Share 5-point trend, +90.9% $54.71 $46.65 $39.31 $31.82 $28.67 · · ·
Cash Flow / Share 5-point trend, +6014.9% $13.17 $8.81 $7.34 $4.45 $0.22 · · ·
Cash / Share 5-point trend, +55.4% $11.94 $5.55 $5.82 $6.47 $7.68 · · ·
EPS (TTM) 5-point trend, +9.5% $7.04 $6.18 $3.39 $2.05 $6.43 · · ·
Stopy Wzrostu 9
Dane roczne Stopy Wzrostu dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Revenue YoY 5-point trend, -82.7% 9.3% 12.8% 9.2% 5.0% 53.7% · · ·
Revenue CAGR 3Y 4-point trend, -44.3% 10.4% 9.0% 20.8% 18.8% · · · ·
Revenue CAGR 5Y 2-point trend, +7.6% 16.8% 15.6% · · · · · ·
EPS YoY 5-point trend, -96.3% 13.9% 82.3% 65.4% -68.1% 372.8% · · ·
EPS CAGR 3Y 3-point trend, +42.9% 50.9% -1.3% 35.6% · · · · ·
EPS CAGR 5Y 38.9% · · · · · · ·
Net Income YoY 5-point trend, -98.2% 6.1% 73.3% 46.5% -70.0% 344.1% · · ·
Net Income CAGR 3Y 3-point trend, +56.6% 39.2% -8.6% 25.0% · · · · ·
Net Income CAGR 5Y 29.1% · · · · · · ·
Wycena (TTM) 13
Dane roczne Wycena (TTM) dla CVSA
Wskaźnik Trend 20262025202420232022202120202019
Revenue TTM 5-point trend, +41.4% $1.95B $1.79B $1.58B $1.45B $1.38B · · ·
Net Income TTM 5-point trend, -19.1% $252M $237M $137M $93M $311M · · ·
Market Cap 5-point trend, +161.1% $4.24B $4.57B $2.57B $1.45B $1.63B · · ·
Enterprise Value 5-point trend, +112.5% $4.50B $4.93B $3.00B $1.87B $2.12B · · ·
P/E 5-point trend, +216.5% 17.7 20.6 20.1 16.8 5.6 · · ·
P/S 5-point trend, +84.6% 2.2 2.6 1.6 1.0 1.2 · · ·
P/B 5-point trend, +171.7% 2.9 3.2 1.9 1.0 1.1 · · ·
P / Cash Flow 5-point trend, -94.2% 9.0 13.5 8.7 7.2 155.9 · · ·
P / FCF 5-point trend, +113.7% 10.8 15.9 10.4 8.8 -78.8 · · ·
EV / EBITDA 5-point trend, -55.4% 11.7 14.4 13.8 11.1 26.3 · · ·
EV / FCF 5-point trend, +111.2% 11.5 17.1 12.2 11.3 -102.6 · · ·
EV / Revenue 5-point trend, +50.3% 2.3 2.8 1.9 1.3 1.5 · · ·
Earnings Yield 5-point trend, -68.4% 5.7% 4.9% 5.0% 6.0% 17.9% · · ·

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2026-06-302025-06-302024-06-302023-06-302022-12-31
Przychody $1.95B$1.79B$1.58B$1.45B
Marża Operacyjna % 19.6%19.1%13.7%11.6%
Zysk netto $252M$237M$137M$93M
Rozwodniony EPS $7.04$6.18$3.39$2.05
Bilans
2026-06-302025-06-302024-06-302023-06-302022-12-31
Dług / Kapitał Własny 0.50.40.50.5
Wskaźnik bieżący 1.10.80.91.1
Wskaźnik Szybkości 1.00.70.70.9
Przepływy pieniężne
2026-06-302025-06-302024-06-302023-06-302022-12-31
Wolny przepływ pieniężny $393M$288M$247M$166M

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Właściciele instytucjonalni (13F) 402 emitenci · $3.0B łącznie · Na dzień 30 czerwca 2026

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
61 (+15 vs poprzedni kw.) 30 (-23 vs poprzedni kw.) 137 (+3 vs poprzedni kw.) 121 (-7 vs poprzedni kw.) +4.5M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
VANGUARD GROUP INC $418 746 711 4 047 035 14,07% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $297 558 184 2 386 958 10,00% Akcje
FMR LLC $280 021 015 2 246 278 9,41% Akcje
DIMENSIONAL FUND ADVISORS LP $208 992 241 1 676 499 7,02% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $183 742 358 1 473 948 6,17% Akcje
STATE STREET CORP $173 212 203 1 389 477 5,82% Akcje
Capital World Investors $132 593 736 1 063 643 4,46% Akcje
GEODE CAPITAL MANAGEMENT, LLC $95 719 361 767 678 3,22% Akcje
WELLINGTON MANAGEMENT GROUP LLP $87 910 731 705 204 2,95% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $78 581 301 630 365 2,64% Akcje
Alyeska Investment Group, L.P. $68 807 458 551 961 2,31% Akcje
Fisher Asset Management, LLC $63 050 035 505 776 2,12% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60 245 186 483 276 2,02% Akcje
NEUMEIER POMA INVESTMENT COUNSEL LLC $44 010 839 353 047 1,48% Akcje
FRONTIER CAPITAL MANAGEMENT CO LLC $37 728 848 302 654 1,27% Akcje
TWO SIGMA INVESTMENTS, LP $32 342 164 259 443 1,09% Akcje
VANGUARD FIDUCIARY TRUST CO $30 437 360 244 163 1,02% Akcje
PRINCIPAL FINANCIAL GROUP INC $26 065 659 209 094 0,88% Akcje
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $23 386 341 187 601 0,79% Akcje
SG Capital Management LLC $22 238 845 178 396 0,75% Akcje
TWO SIGMA ADVISERS, LP $19 876 587 192 100 0,67% Akcje
ALGERT GLOBAL LLC $19 323 048 155 006 0,65% Akcje
MORGAN STANLEY $18 731 418 150 260 0,63% Akcje
Public Sector Pension Investment Board $17 393 810 139 530 0,58% Akcje
Corient Private Wealth LP $16 950 396 135 973 0,57% Akcje
WESTPORT ASSET MANAGEMENT INC $15 677 117 125 759 0,53% Akcje
Bank of New York Mellon Corp $15 262 248 122 431 0,51% Akcje
PRUDENTIAL FINANCIAL INC $14 091 816 113 042 0,47% Akcje
MACKENZIE FINANCIAL CORP $13 510 152 108 376 0,45% Akcje
Qube Research & Technologies Ltd $12 647 380 101 455 0,43% Akcje
BANK OF AMERICA CORP /DE/ $12 502 650 100 294 0,42% Akcje
RHUMBLINE ADVISERS $10 647 181 85 410 0,36% Akcje
MILLENNIUM MANAGEMENT LLC $9 671 247 77 581 0,33% Akcje
Foresight Group Ltd Liability Partnership $9 636 366 77 264 0,32% Akcje
AMERICAN CENTURY COMPANIES INC $9 436 388 75 697 0,32% Akcje
ALLIANCEBERNSTEIN L.P. $8 879 782 77 048 0,30% Akcje
BlackRock, Inc. $8 832 036 70 849 0,30% Akcje
LAZARD ASSET MANAGEMENT LLC $8 696 157 69 759 0,29% Akcje
Swiss National Bank $8 638 938 69 300 0,29% Akcje
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $8 557 000 68 639 0,29% Akcje
Universal- Beteiligungs- und Servicegesellschaft mbH $8 419 536 67 540 0,28% Akcje
Hillsdale Investment Management Inc. $8 077 968 64 800 0,27% Akcje
BNP PARIBAS FINANCIAL MARKETS $8 030 847 64 422 0,27% Akcje
RENAISSANCE GROUP LLC $7 608 748 61 036 0,26% Akcje
AMERIPRISE FINANCIAL INC $7 563 622 60 674 0,25% Akcje
GOLDMAN SACHS GROUP INC $7 528 716 60 394 0,25% Akcje
Allianz Asset Management GmbH $7 053 013 56 578 0,24% Akcje
LONESTAR CAPITAL MANAGEMENT LLC $6 856 300 55 000 0,23% Akcje
Legal & General Group Plc $6 503 387 52 169 0,22% Akcje
Phocas Financial Corp. $6 345 443 50 902 0,21% Akcje
WEDGE CAPITAL MANAGEMENT L L P/NC $6 335 869 54 975 0,21% Akcje
FIRST TRUST ADVISORS LP $6 152 968 49 358 0,21% Akcje
ExodusPoint Capital Management, LP $5 906 141 47 378 0,20% Akcje
KESTREL INVESTMENT MANAGEMENT CORP $5 896 418 47 300 0,20% Akcje
LEUTHOLD GROUP, LLC $5 622 914 45 106 0,19% Akcje
ENVESTNET ASSET MANAGEMENT INC $5 482 297 43 978 0,18% Akcje
Connor, Clark & Lunn Investment Management Ltd. $5 313 757 42 626 0,18% Akcje
LGT Fund Management Co Ltd. $4 992 633 40 050 0,17% Akcje
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $4 840 500 42 000 0,16% Akcje
Trexquant Investment LP $4 814 120 38 618 0,16% Akcje
FARLEY CAPITAL L.P. $4 644 333 37 256 0,16% Akcje
SEI INVESTMENTS CO $4 541 490 36 431 0,15% Akcje
CHURCHILL MANAGEMENT Corp $4 474 806 35 171 0,15% Akcje
INTECH INVESTMENT MANAGEMENT LLC $4 270 726 34 259 0,14% Akcje
VANGUARD ASSET MANAGEMENT, Ltd $3 909 088 31 358 0,13% Akcje
HSBC HOLDINGS PLC $3 726 330 29 614 0,13% Akcje
PANAGORA ASSET MANAGEMENT INC $3 568 268 28 624 0,12% Akcje
Smith Group Asset Management, LLC $3 304 113 26 505 0,11% Akcje
OP Asset Management Ltd $3 295 387 26 435 0,11% Akcje
Horizon Investments, LLC $3 257 730 21 000 0,11% Akcje
Atom Investors LP $3 165 242 25 391 0,11% Akcje
FORMULA GROWTH LTD $3 140 933 25 196 0,11% Akcje
STATE OF WISCONSIN INVESTMENT BOARD $3 064 891 24 586 0,10% Akcje
BARCLAYS PLC $2 926 019 23 472 0,10% Akcje
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $2 840 627 22 787 0,10% Akcje
NewEdge Wealth, LLC $2 790 514 22 385 0,09% Akcje
Elo Mutual Pension Insurance Co $2 724 943 21 859 0,09% Akcje
RENAISSANCE TECHNOLOGIES LLC $2 717 588 21 800 0,09% Akcje
NEW YORK STATE COMMON RETIREMENT FUND $2 695 523 21 623 0,09% Akcje
MetLife Investment Management, LLC $2 499 807 20 053 0,08% Akcje
Global Alpha Capital Management Ltd. $2 430 995 19 501 0,08% Akcje
FIFTH THIRD BANCORP $2 403 502 19 280 0,08% Akcje
ROYCE & ASSOCIATES LP $2 376 768 19 066 0,08% Akcje
Boston Partners $2 293 116 18 393 0,08% Akcje
Quantinno Capital Management LP $2 288 134 18 355 0,08% Akcje
Grantham, Mayo, Van Otterloo & Co. LLC $2 256 097 18 098 0,08% Akcje
LGT CAPITAL PARTNERS LTD. $2 206 482 17 700 0,07% Akcje
IEQ CAPITAL, LLC $2 199 751 17 646 0,07% Akcje
VIRGINIA RETIREMENT SYSTEMS ET Al $2 141 829 20 700 0,07% Akcje
Bridgewater Associates, LP $2 138 044 17 151 0,07% Akcje
CITIGROUP INC $2 106 879 16 901 0,07% Akcje
CITADEL ADVISORS LLC $2 106 754 16 900 0,07% Opcja kupna
Banque Cantonale Vaudoise $2 082 000 16 700 0,07% Akcje
Mariner, LLC $2 075 942 16 653 0,07% Akcje
MANUFACTURERS LIFE INSURANCE COMPANY, THE $2 064 120 16 558 0,07% Akcje
Illinois Municipal Retirement Fund $2 054 147 16 478 0,07% Akcje
Gotham Asset Management, LLC $2 014 256 16 158 0,07% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1 982 094 15 900 0,07% Opcja kupna
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $1 977 731 15 865 0,07% Akcje
Zurcher Kantonalbank (Zurich Cantonalbank) $1 902 312 15 260 0,06% Akcje

Insiderzy spółki 111 insiderów · 46 dyrektorzy generalni · 24 dyrektorzy

Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Daniel Hamburger President and CEO 31 sierpnia 2015 S 142 136 0 0 $0
Michael O Randolfi SVP, Chief Financial Officer 28 sierpnia 2020 F 84 391 0 0 $0
Timothy J Wiggins SVP & Chief Financial Officer 25 lutego 2016 S 44 939 0 0 $0
Richard Gunst Chief Financial Officer 1 lutego 2012 M 9 356 0 0 $0
Amelia Manning President, Chamberlain Univ. 15 lipca 2026 A 4 317 0 0 $0
Karen Sue Cox President, Chamberlain Univ. 8 maja 2026 S 31 596 0 1 $-249 000
Scott Liles President, Medical and Vet 15 kwietnia 2026 F 13 103 0 0 $0
Evan Trent President, Adtalem Elevate 13 listopada 2025 F 24 134 0 0 $0
Thiago Aguiar Sayao Group President, Business &Law 28 lutego 2020 S 1 830 0 0 $0
Carlos Filgueiras Group President, Tech/Business 13 lutego 2019 S 11 775 0 0 $0
Donna M Loraine President, Carrington Colleges 6 listopada 2018 M 6 701 0 0 $0
Susan Groenwald President, Chamberlain 9 lutego 2018 M 34 402 0 0 $0
John P Roselli President, Becker Professional 1 września 2017 S 13 730 0 0 $0
Eric P. Dirst President, ATGE Shared Ops 31 sierpnia 2017 S 14 800 0 0 $0
Robert A Paul President, DeVry University 25 sierpnia 2017 M 28 426 0 0 $0
Steven Riehs President, Med, Prof & Online 2 września 2016 M 28 062 0 0 $0
Jeffrey Richard Akens President, Carrington College 29 sierpnia 2015 F 6 752 0 0 $0
Christopher Caywood President, Online Services 1 marca 2013 F 7 378 0 0 $0
Andrew A Jeon President, DeVry Medical Int'l 2 listopada 2012 F 5 655 0 0 $0
William B. Hughson President, Medical & 29 sierpnia 2012 A 2 143 0 0 $0
Manjunath Gangadharan VP, Chief Accounting Officer 18 maja 2026 F 5 271 0 1 $-128 072
Michael Betz Pres. Walden University & CDO 13 listopada 2025 F 33 286 0 0 $0
Maurice Herrera SVP - Chief Marketing Officer 13 listopada 2025 F 20 584 0 0 $0
Megan Noel Chief Corp. Affairs Officer 12 listopada 2025 A 2 226 0 0 $0
Sara Hill CHRO 12 listopada 2025 A 10 276 0 0 $0
Blake Simpson SVP, Chief Comms & CA Officer 5 grudnia 2024 F 8 795 0 0 $0
Steven Tom SVP Chief Customer Officer 13 listopada 2024 A 13 255 0 0 $0
Cheryl James SVP, CHRO 28 lutego 2024 F 17 485 0 0 $0
John W Danaher MD Pres. - Adtalem Med & Vet 25 sierpnia 2023 F 38 718 0 0 $0
James Raymond Bartholomew SVP - Chamberlain University 26 sierpnia 2022 F 6 418 0 0 $0
Holland Katherine Alice Boden Group Pres, Adtalem Health 30 sierpnia 2021 F 32 148 0 0 $0
Fernando Lau SVP, Chief Marketing Officer 28 sierpnia 2021 F 19 253 0 0 $0
Christopher C Nash SVP, Chief Information Officer 28 sierpnia 2021 F 25 741 0 0 $0
Donna Jennings SVP, Human Resources 28 sierpnia 2021 F 30 898 0 0 $0
Chaka M Patterson SVP and General Counsel 28 sierpnia 2020 F 5 202 0 0 $0
Mehul R Patel Group Pres, Financial Services 7 listopada 2019 F 11 258 0 0 $0
Kathleen Carroll Vice President, Controller 28 sierpnia 2019 A 5 497 0 0 $0
Lisa M Sodeika SVP, Corporate Affairs 28 sierpnia 2019 A 24 151 0 0 $0
Patrick J Unzicker Principal Financial Officer 27 sierpnia 2019 F 36 360 0 0 $0
Catherine C. Anderson SVP, Strategy & Innovation 26 sierpnia 2019 F 6 025 0 0 $0
Gena L Ashe SVP, CLO and Secretary 23 sierpnia 2017 A 4 420 0 0 $0
Gregory S Davis SVP and General Counsel 1 września 2016 S 22 433 0 0 $0
Adriano Allegrini VP, Strategy and Bus. Develop. 29 sierpnia 2015 F 7 004 0 0 $0
Sharon Thomas Parrott SVP, Gov. & Regulatory Affairs 5 listopada 2014 A 5 610 0 0 $0
David J Pauldine Executive Vice President & 25 kwietnia 2014 M 30 242 0 0 $0
Thomas C Shepherd Executive Vice President and 27 maja 2011 M 0 0 0 $0
Michael W Malafronte Dyrektor 11 marca 2026 P 25 395 5 0 $3 844 716
William V Krehbiel Dyrektor 13 listopada 2025 F 16 303 0 0 $0
Betty M. Vandenbosch Dyrektor 13 listopada 2025 F 2 584 0 0 $0
Kenneth J Phelan Dyrektor 13 listopada 2025 F 19 836 1 0 $49 931

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Aktywiści i właściciele 5%+ 1 akcja

Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.

Zgłaszający Złożono Udział Status Cel Zgłoszenie
International Value Advisers, LLC, Charles de Vaulx ×18 zgłoszenia 7 sierpnia 2020 Pierwotne zgłoszenie SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Posiadanie ETF-ów Posiadane przez 79 funduszy ETF

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
PSCD · Invesco Exchange-Traded Fund Trust … 1,82% 3 165 SH 8 sierpnia 2026 Dziennie
PSL · Invesco Exchange-Traded Fund Trust 1,76% 10 579 SH 8 sierpnia 2026 Dziennie
MYLD · Cambria ETF Trust 0,94% 2 418 NS 30 kwietnia 2026 N-PORT
XSHQ · Invesco Exchange-Traded Fund Trust … 0,91% 20 685 SH 8 sierpnia 2026 Dziennie
RZG · Invesco Exchange-Traded Fund Trust 0,88% 8 705 SH 8 sierpnia 2026 Dziennie
CGMM · Capital Group Equity ETF Trust I 0,80% 190 016 NS 31 maja 2026 N-PORT
VUSE · ETF Series Solutions 0,53% 31 159 NS 31 maja 2026 N-PORT
IJT · iShares Trust 0,47% 316 256 SH 8 sierpnia 2026 Dziennie
CAFG · Pacer Funds Trust 0,47% 919 NS 30 kwietnia 2026 N-PORT
VIOG · VANGUARD ADMIRAL FUNDS 0,46% 40 509 SH 8 sierpnia 2026 Dziennie
CALF · Pacer Funds Trust 0,46% 136 827 NS 30 kwietnia 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,33% 29 825 NS 30 kwietnia 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0,27% 4 982 SH 8 sierpnia 2026 Dziennie
XJR · iShares Trust 0,26% 4 021 SH 8 sierpnia 2026 Dziennie
IWO · iShares Trust 0,26% 312 826 SH 8 sierpnia 2026 Dziennie
PRFZ · Invesco Exchange-Traded Fund Trust 0,26% 52 359 SH 8 sierpnia 2026 Dziennie
VTWG · VANGUARD SCOTTSDALE FUNDS 0,25% 36 861 SH 8 sierpnia 2026 Dziennie
IJR · iShares Trust 0,23% 2 075 461 SH 8 sierpnia 2026 Dziennie
VIOO · VANGUARD ADMIRAL FUNDS 0,23% 119 030 SH 8 sierpnia 2026 Dziennie
JPSE · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 10 711 NS 30 kwietnia 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,21% 4 228 SH 8 sierpnia 2026 Dziennie
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 13 071 NS 30 kwietnia 2026 N-PORT
SMDX · Tidal Trust III 0,20% 2 228 NS 30 kwietnia 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,20% 46 807 NS 31 maja 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,18% 1 290 NS 30 kwietnia 2026 N-PORT
DFAT · Dimensional ETF Trust 0,18% 217 961 NS 30 kwietnia 2026 N-PORT
SAA · ProShares Trust 0,18% 412 NS 31 maja 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,14% 29 761 NS 30 kwietnia 2026 N-PORT
GMOV · GMO ETF Trust 0,14% 1 078 NS 31 maja 2026 N-PORT
IWM · iShares Trust 0,13% 875 500 SH 8 sierpnia 2026 Dziennie
ISCG · iShares Trust 0,13% 10 563 SH 8 sierpnia 2026 Dziennie
VTWO · VANGUARD SCOTTSDALE FUNDS 0,13% 198 216 SH 8 sierpnia 2026 Dziennie
FNDA · SCHWAB STRATEGIC TRUST 0,13% 98 138 NS 31 maja 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0,13% 19 006 SH 8 sierpnia 2026 Dziennie
SMLF · iShares Trust 0,12% 41 596 SH 8 sierpnia 2026 Dziennie
VFQY · VANGUARD WELLINGTON FUND 0,12% 4 599 SH 8 sierpnia 2026 Dziennie
PKW · Invesco Exchange-Traded Fund Trust 0,12% 15 066 SH 8 sierpnia 2026 Dziennie
VCR · VANGUARD WORLD FUND 0,12% 67 714 SH 8 sierpnia 2026 Dziennie
RSSL · Global X Funds 0,12% 14 797 NS 30 kwietnia 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0,11% 12 017 NS 30 kwietnia 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,11% 9 365 NS 31 maja 2026 N-PORT
FDIS · FIDELITY COVINGTON TRUST 0,10% 15 550 NS 30 kwietnia 2026 N-PORT
ITWO · ProShares Trust 0,10% 1 606 NS 31 maja 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,10% 5 421 SH 8 sierpnia 2026 Dziennie
DFAS · Dimensional ETF Trust 0,09% 111 249 NS 30 kwietnia 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,09% 470 701 SH 8 sierpnia 2026 Dziennie
SCHA · SCHWAB STRATEGIC TRUST 0,09% 165 865 NS 31 maja 2026 N-PORT
ESML · iShares Trust 0,07% 16 803 SH 8 sierpnia 2026 Dziennie
FAD · First Trust Exchange-Traded AlphaDE… 0,07% 2 779 NS 30 kwietnia 2026 N-PORT
ISCB · iShares Trust 0,06% 1 479 SH 8 sierpnia 2026 Dziennie